Danny Tobey is a medical doctor and software entrepreneur who represents life sciences, technology and healthcare clients in all manner of disputes, from tort and contract claims to regulatory and patent cases. He also advises life sciences companies and funds as outside general counsel. Danny also leads the firm's team that focuses on efforts to assist companies as they navigate the legal landscape of emerging and disruptive technologies, while helping them understand the legal and compliance risks arising from the creation and deployment of AI systems. In 2019, Danny received a Burton Award from the Library of Congress recognizing "the best of the best writers in the legal profession" among the nation's top 1,000 largest law firms.

A graduate of Harvard College, Yale Law School, and UT Southwestern Medical School, Danny has litigated successfully some of his clients' most challenging and important cases. He designed the winning scientific case in the first Hatch-Waxman suit in the Eastern District of Texas. He obtained a unanimous reversal in federal appellate court in an R&D tax case of first impression, leading to a highly-cited published opinion and increasing his clients' tax refund from low-six to high-seven figures. He has successfully handled as lead counsel litigations arising from M&A transactions for a molecular diagnostics company and others. He has represented healthcare and hospital clients in matters ranging from credentialing and internal investigation to peer review and business tort claims.

Danny has been a thought leader on emerging legal issues in medicine and AI. His writing has appeared in the National Law Journal, the 2018 Proceedings of the Association for the Advancement of Artificial Intelligence, Yale Journal of Law & Technology and Health Law Litigation. He has consulted with companies ranging from startups to Fortune 100 on legal issues in the creation and adoption of AI. He serves on the Continuously Learning Systems task force with leading industry representatives. His original medical research is published in Pediatric Blood & Cancer and the Journal of Child and Adolescent Psychopharmacology.

Beyond healthcare, Danny has represented private equity, finance and other clients in some of their most pressing cases in state and federal court.

Danny serves on the executive committees of the Yale Law School Association, the Parkland Foundation supporting the Parkland Health and Hospital System and the AT&T Performing Arts Center. He serves on the boards of directors of the Perot Museum of Nature and Science, the SPCA of Texas and the regional Anti-Defamation League. He has co-chaired the Judiciary and Membership & Admissions Committees of the Dallas Bar Association and sits on the governing council of its Business Litigation Section.